Harvard Bioscience (HBIO) FCF Margin Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 156.17 Bn | 151.78 Bn | 1.83 Bn |
| 2 | Becton Dickinson | 41.51 Bn | 40.49 Bn | 2.15 Bn |
| 3 | Resmed | 30.43 Bn | 28.77 Bn | 890.98 Mn |
| 4 | West Pharmaceutical Services | 22.78 Bn | 22.26 Bn | 296.40 Mn |
| 5 | Solventum | 13.39 Bn | 13.39 Bn | 1.10 Bn |
| 6 | Cooper Companies | 12.33 Bn | 12.20 Bn | 695.20 Mn |
| 7 | Align Technology | 11.65 Bn | 10.59 Bn | 736.59 Mn |
| 8 | Baxter International | 9.81 Bn | 7.77 Bn | 891.00 Mn |
| 9 | Aptargroup | 7.39 Bn | 7.19 Bn | 351.91 Mn |
| 10 | Harvard Bioscience | 25.38 Mn | 18.29 Mn | 12.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -852.00 |
| Dec 31, 2025 | -1,013.00 |
| Sep 30, 2025 | -4.00 |
| Jun 30, 2025 | 407.00 |
| Mar 31, 2025 | 29.00 |
| Dec 31, 2024 | 5.00 |
| Sep 30, 2024 | -1,806.00 |
| Jun 30, 2024 | -848.00 |
| Mar 31, 2024 | -353.00 |
| Dec 31, 2023 | 496.00 |
| Sep 30, 2023 | 2,224.00 |
| Jun 30, 2023 | 695.00 |
| Mar 31, 2023 | 547.00 |
| Dec 31, 2022 | 1,392.00 |
| Sep 30, 2022 | -933.00 |
| Jun 30, 2022 | -341.00 |
| Mar 31, 2022 | -407.00 |
| Dec 31, 2021 | -1,622.00 |
| Sep 30, 2021 | -1,231.00 |
| Jun 30, 2021 | -399.00 |
| Mar 31, 2021 | 672.00 |
| Dec 31, 2020 | -1,692.00 |
| Sep 30, 2020 | 716.00 |
| Jun 30, 2020 | 1,997.00 |
| Mar 31, 2020 | 894.00 |
| Dec 31, 2019 | -98.00 |
| Sep 30, 2019 | 597.00 |
| Jun 30, 2019 | -568.00 |
| Mar 31, 2019 | 139.00 |
| Dec 31, 2018 | 98.00 |
| Sep 30, 2018 | -1,360.00 |
| Jun 30, 2018 | -36.00 |
| Mar 31, 2018 | -373.00 |
| Dec 31, 2017 | -1,249.00 |
| Sep 30, 2017 | -156.00 |
| Jun 30, 2017 | -880.00 |
| Mar 31, 2017 | -1,118.00 |
| Dec 31, 2016 | 517.00 |
| Sep 30, 2016 | 280.00 |
| Jun 30, 2016 | -173.00 |
| Mar 31, 2016 | -947.00 |
| Dec 31, 2015 | 958.00 |
| Sep 30, 2015 | -1,056.00 |